Reported Earnings • Mar 05
Full year 2025 earnings released: Mex$0.41 loss per share (vs Mex$1.85 loss in FY 2024) Full year 2025 results: Mex$0.41 loss per share (improved from Mex$1.85 loss in FY 2024). Revenue: Mex$710.4m (down 38% from FY 2024). Net loss: Mex$441.1m (loss narrowed 30% from FY 2024). お知らせ • Mar 03
Proteak Uno, S.A.B. de C.V., Annual General Meeting, Mar 19, 2026 Proteak Uno, S.A.B. de C.V., Annual General Meeting, Mar 19, 2026. Location: juan salvador agraz, no 97 3rd floor office 3b santa fe, cuajimalpa cp 05348, mexico Mexico Buy Or Sell Opportunity • Jan 02
Now 61% overvalued Over the last 90 days, the stock has fallen 65% to Mex$0.091. The fair value is estimated to be Mex$0.056, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Meanwhile, the company became loss making. New Risk • Dec 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Mexican stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 42% per year over the past 5 years. Market cap is less than US$10m (Mex$80.5m market cap, or US$4.47m). Minor Risk Share price has been volatile over the past 3 months (6.0% average weekly change). Reported Earnings • Oct 30
Third quarter 2025 earnings released: Mex$0.20 loss per share (vs Mex$0.74 loss in 3Q 2024) Third quarter 2025 results: Mex$0.20 loss per share (improved from Mex$0.74 loss in 3Q 2024). Revenue: Mex$158.2m (down 47% from 3Q 2024). Net loss: Mex$74.2m (loss narrowed 73% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has fallen by 60% per year, which means it is performing significantly worse than earnings. Reported Earnings • Jul 29
Second quarter 2025 earnings released Second quarter 2025 results: Revenue: Mex$34.0m (down 89% from 2Q 2024). Net loss: Mex$40.3m (loss narrowed 83% from 2Q 2024). Reported Earnings • May 04
First quarter 2025 earnings released First quarter 2025 results: Revenue: Mex$316.1m (down 11% from 1Q 2024). Net loss: Mex$168.9m (loss widened 192% from 1Q 2024). Buy Or Sell Opportunity • Apr 21
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 36% to Mex$0.35. The fair value is estimated to be Mex$0.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company became loss making. お知らせ • Apr 15
Proteak Uno, S.A.B. de C.V., Annual General Meeting, Apr 30, 2025 Proteak Uno, S.A.B. de C.V., Annual General Meeting, Apr 30, 2025. Location: juan salvador agraz, no 97 3rd floor office 3b santa fe, cuajimalpa cp 05348, mexico Mexico Buy Or Sell Opportunity • Apr 02
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 89% to Mex$0.53. The fair value is estimated to be Mex$0.44, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company became loss making. New Risk • Mar 16
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: Mex$192.5m (US$9.66m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (22% average weekly change). Earnings have declined by 27% per year over the past 5 years. Market cap is less than US$10m (Mex$192.5m market cap, or US$9.66m). Buy Or Sell Opportunity • Mar 10
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 93% to Mex$0.60. The fair value is estimated to be Mex$0.50, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Mar 02
Full year 2024 earnings released: Mex$1.85 loss per share (vs Mex$0.82 loss in FY 2023) Full year 2024 results: Mex$1.85 loss per share (further deteriorated from Mex$0.82 loss in FY 2023). Revenue: Mex$1.19b (down 15% from FY 2023). Net loss: Mex$682.2m (loss widened 144% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 38 percentage points per year, which is a significant difference in performance. Board Change • Jan 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. Director Ricardo Haua was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 02
Third quarter 2024 earnings released: Mex$0.80 loss per share (vs Mex$0.33 loss in 3Q 2023) Third quarter 2024 results: Mex$0.80 loss per share (further deteriorated from Mex$0.33 loss in 3Q 2023). Revenue: Mex$295.8m (down 12% from 3Q 2023). Net loss: Mex$294.8m (loss widened 140% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 32 percentage points per year, which is a significant difference in performance. New Risk • Sep 25
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: Mex$193.9m (US$9.91m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.5% average weekly change). Earnings have declined by 14% per year over the past 5 years. Market cap is less than US$10m (Mex$193.9m market cap, or US$9.91m). New Risk • Aug 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Mexican stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 14% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.7% average weekly change). Market cap is less than US$100m (Mex$321.4m market cap, or US$16.2m). Reported Earnings • Jul 27
Second quarter 2024 earnings released: Mex$0.73 loss per share (vs Mex$0.03 loss in 2Q 2023) Second quarter 2024 results: Mex$0.73 loss per share (further deteriorated from Mex$0.03 loss in 2Q 2023). Revenue: Mex$295.4m (down 22% from 2Q 2023). Net loss: Mex$268.6m (loss widened Mex$256.0m from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance. New Risk • May 01
New minor risk - Financial position The company has less than a year of cash runway based on its current free cash flow. Free cash flow: -Mex$56m This is considered a minor risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.1% average weekly change). Earnings have declined by 6.0% per year over the past 5 years. Minor Risks Less than 1 year of cash runway based on current free cash flow (-Mex$56m). Market cap is less than US$100m (Mex$467.9m market cap, or US$27.5m). Reported Earnings • May 01
First quarter 2024 earnings released First quarter 2024 results: Revenue: Mex$355.2m (down 14% from 1Q 2023). Net loss: Mex$61.7m (down 454% from profit in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance. New Risk • Feb 29
New major risk - Revenue and earnings growth Earnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (6.7% average weekly change). Earnings have declined by 1.7% per year over the past 5 years. Minor Risk Market cap is less than US$100m (Mex$599.0m market cap, or US$35.1m). Reported Earnings • Feb 29
Full year 2023 earnings released: Mex$0.94 loss per share (vs Mex$0.82 loss in FY 2022) Full year 2023 results: Mex$0.94 loss per share (further deteriorated from Mex$0.82 loss in FY 2022). Revenue: Mex$1.41b (down 27% from FY 2022). Net loss: Mex$351.1m (loss widened 15% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance. Reported Earnings • Oct 31
Third quarter 2023 earnings released: Mex$0.11 loss per share (vs Mex$0.03 loss in 3Q 2022) Third quarter 2023 results: Mex$0.11 loss per share (further deteriorated from Mex$0.03 loss in 3Q 2022). Revenue: Mex$335.5m (down 27% from 3Q 2022). Net loss: Mex$123.0m (loss widened Mex$110.1m from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 20% per year, which means it has not declined as severely as earnings. Reported Earnings • Jul 31
Second quarter 2023 earnings released: Mex$0.01 loss per share (vs Mex$0.09 loss in 2Q 2022) Second quarter 2023 results: Mex$0.01 loss per share (improved from Mex$0.09 loss in 2Q 2022). Revenue: Mex$379.0m (down 23% from 2Q 2022). Net loss: Mex$12.6m (loss narrowed 54% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. New Risk • Jul 01
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 35% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.7x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (9.8% net profit margin). Market cap is less than US$100m (Mex$1.13b market cap, or US$66.1m). Reported Earnings • Mar 02
Full year 2022 earnings released: EPS: Mex$0.56 (vs Mex$0.69 in FY 2021) Full year 2022 results: EPS: Mex$0.56 (down from Mex$0.69 in FY 2021). Revenue: Mex$1.96b (up 1.0% from FY 2021). Net income: Mex$208.4m (down 5.4% from FY 2021). Profit margin: 11% (in line with FY 2021). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 7 highly experienced directors. Independent Director Ricardo Elizondo Guajardo was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 29
Third quarter 2022 earnings released: Mex$0.039 loss per share (vs Mex$0.14 profit in 3Q 2021) Third quarter 2022 results: Mex$0.039 loss per share (down from Mex$0.14 profit in 3Q 2021). Revenue: Mex$441.8m (down 25% from 3Q 2021). Net loss: Mex$14.7m (down 133% from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 89% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings. Reported Earnings • Jul 29
Second quarter 2022 earnings released: EPS: Mex$0.16 (vs Mex$0.60 in 2Q 2021) Second quarter 2022 results: EPS: Mex$0.16 (down from Mex$0.60 in 2Q 2021). Revenue: Mex$490.2m (down 7.6% from 2Q 2021). Net loss: Mex$27.2m (down 114% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 94% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Jun 30
Investor sentiment deteriorated over the past week After last week's 17% share price decline to Mex$3.51, the stock trades at a trailing P/E ratio of 2.8x. Average trailing P/E is 4x in the Forestry industry in South America. Total loss to shareholders of 62% over the past three years. Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment deteriorated over the past week After last week's 17% share price decline to Mex$4.00, the stock trades at a trailing P/E ratio of 3.2x. Average trailing P/E is 5x in the Forestry industry in South America. Total loss to shareholders of 60% over the past three years. Reported Earnings • May 05
First quarter 2022 earnings released: EPS: Mex$0.19 (vs Mex$0.19 loss in 1Q 2021) First quarter 2022 results: EPS: Mex$0.19 (up from Mex$0.19 loss in 1Q 2021). Revenue: Mex$640.5m (up 38% from 1Q 2021). Net income: Mex$183.9m (up Mex$245.3m from 1Q 2021). Profit margin: 29% (up from net loss in 1Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 7 highly experienced directors. Independent Director Ricardo Elizondo Guajardo was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 04
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: Mex$0.66 (up from Mex$0.64 loss in FY 2020). Revenue: Mex$1.98b (up 70% from FY 2020). Net income: Mex$247.6m (up Mex$452.9m from FY 2020). Profit margin: 13% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings. Board Change • Dec 05
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 5 highly experienced directors. Independent Director Ricardo Elizondo Guajardo was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment improved over the past week After last week's 19% share price gain to Mex$5.96, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 8x in the Forestry industry in South America. Total loss to shareholders of 49% over the past three years. Reported Earnings • Jul 31
Second quarter 2021 earnings released: EPS Mex$0.56 (vs Mex$0.003 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: Mex$493.7m (up 96% from 2Q 2020). Net income: Mex$210.9m (up Mex$211.8m from 2Q 2020). Profit margin: 43% (up from net loss in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. Reported Earnings • Mar 04
Full year 2020 earnings released: Mex$0.74 loss per share (vs Mex$0.21 loss in FY 2019) The company reported a soft full year result with increased losses and weaker control over costs, although revenues improved. Full year 2020 results: Revenue: Mex$1.36b (up 1.6% from FY 2019). Net loss: Mex$236.1m (loss widened 250% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has fallen by 34% per year, which means it is performing significantly worse than earnings. Is New 90 Day High Low • Feb 24
New 90-day high: Mex$5.44 The company is up 9.0% from its price of Mex$5.00 on 24 November 2020. The Mexican market is up 6.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Forestry industry, which is up 36% over the same period. Is New 90 Day High Low • Jan 28
New 90-day low: Mex$3.80 The company is down 3.0% from its price of Mex$3.90 on 30 October 2020. The Mexican market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Forestry industry, which is up 21% over the same period. Is New 90 Day High Low • Nov 07
New 90-day high: Mex$4.02 The company is up 15% from its price of Mex$3.51 on 07 August 2020. The Mexican market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Forestry industry, which is up 8.0% over the same period.